Skip to main content
. 2017 Sep;83:302–312. doi: 10.1016/j.ejca.2017.05.037

Fig. 1.

Fig. 1

: Trial profile. aMultiple reasons were recorded and frequencies reporting the top four reasons are given here; bincludes grade 3 or 4 non-haematological or symptomatic grade 4 haematological; cdied within 28 d of day 1 of the last cycle received.